Copyright Reports & Markets. All rights reserved.

Global In-Vitro Diagnostics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

1 COVID-19 In-Vitro Diagnostics Market Overview

  • 1.1 Product Overview and Scope of COVID-19 In-Vitro Diagnostics
  • 1.2 Classification of COVID-19 In-Vitro Diagnostics by Type
    • 1.2.1 Global COVID-19 In-Vitro Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
    • 1.2.2 Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Type in 2019
    • 1.2.3 Rapid Diagnostic Test (RDT)
    • 1.2.4 Enzyme Linked Immunosorbent Assay (ELISA)
    • 1.2.5 Neutralization Assay
  • 1.3 Global COVID-19 In-Vitro Diagnostics Market by Application
    • 1.3.1 Overview: Global COVID-19 In-Vitro Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
    • 1.3.2 Home
    • 1.3.3 Hospital
    • 1.3.4 Clinical
  • 1.4 Global COVID-19 In-Vitro Diagnostics Market by Regions
    • 1.4.1 Global COVID-19 In-Vitro Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
    • 1.4.2 Global Market Size of COVID-19 In-Vitro Diagnostics (2015-2025)
    • 1.4.3 North America (USA, Canada and Mexico) COVID-19 In-Vitro Diagnostics Status and Prospect (2015-2025)
    • 1.4.4 Europe (Germany, France, UK, Russia and Italy) COVID-19 In-Vitro Diagnostics Status and Prospect (2015-2025)
    • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) COVID-19 In-Vitro Diagnostics Status and Prospect (2015-2025)
    • 1.4.6 South America (Brazil, Argentina, Colombia) COVID-19 In-Vitro Diagnostics Status and Prospect (2015-2025)
    • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) COVID-19 In-Vitro Diagnostics Status and Prospect (2015-2025)
  • 1.5 COVID-19 Outbreak: COVID-19 In-Vitro Diagnostics Industry Impact
    • 1.5.1 COVID-19 Potential Implications for the COVID-19 In-Vitro Diagnostics
      • 1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on COVID-19 In-Vitro Diagnostics
      • 1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
      • 1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
      • 1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
    • 1.5.2 Opportunity Analysis in Covid-19 Crisis
    • 1.5.3 Market Risk and Restraints
    • 1.5.4 Market Driving Force

2 Company Profiles

  • 2.1 Cellex
    • 2.1.1 Cellex Details
    • 2.1.2 Cellex Major Business and Total Revenue (Financial Highlights) Analysis
    • 2.1.3 Cellex SWOT Analysis
    • 2.1.4 Cellex Product and Services
    • 2.1.5 Cellex COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
  • 2.2 Mayo Clinic Laboratories
    • 2.2.1 Mayo Clinic Laboratories Details
    • 2.2.2 Mayo Clinic Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
    • 2.2.3 Mayo Clinic Laboratories SWOT Analysis
    • 2.2.4 Mayo Clinic Laboratories Product and Services
    • 2.2.5 Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
  • 2.3 BioMedomics
    • 2.3.1 BioMedomics Details
    • 2.3.2 BioMedomics Major Business and Total Revenue (Financial Highlights) Analysis
    • 2.3.3 BioMedomics SWOT Analysis
    • 2.3.4 BioMedomics Product and Services
    • 2.3.5 BioMedomics COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
  • 2.4 Abbott
    • 2.4.1 Abbott Details
    • 2.4.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
    • 2.4.3 Abbott SWOT Analysis
    • 2.4.4 Abbott Product and Services
    • 2.4.5 Abbott COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
  • 2.5 Safecare Bio-Tech
    • 2.5.1 Safecare Bio-Tech Details
    • 2.5.2 Safecare Bio-Tech Major Business and Total Revenue (Financial Highlights) Analysis
    • 2.5.3 Safecare Bio-Tech SWOT Analysis
    • 2.5.4 Safecare Bio-Tech Product and Services
    • 2.5.5 Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
  • 2.6 Roche
    • 2.6.1 Roche Details
    • 2.6.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
    • 2.6.3 Roche SWOT Analysis
    • 2.6.4 Roche Product and Services
    • 2.6.5 Roche COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
  • 2.7 Mount Sinai Laboratory
    • 2.7.1 Mount Sinai Laboratory Details
    • 2.7.2 Mount Sinai Laboratory Major Business and Total Revenue (Financial Highlights) Analysis
    • 2.7.3 Mount Sinai Laboratory SWOT Analysis
    • 2.7.4 Mount Sinai Laboratory Product and Services
    • 2.7.5 Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
  • 2.8 Henry Schein
    • 2.8.1 Henry Schein Details
    • 2.8.2 Henry Schein Major Business and Total Revenue (Financial Highlights) Analysis
    • 2.8.3 Henry Schein SWOT Analysis
    • 2.8.4 Henry Schein Product and Services
    • 2.8.5 Henry Schein COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
  • 2.9 BD
    • 2.9.1 BD Details
    • 2.9.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
    • 2.9.3 BD SWOT Analysis
    • 2.9.4 BD Product and Services
    • 2.9.5 BD COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
  • 2.10 Chembio Diagnostics
    • 2.10.1 Chembio Diagnostics Details
    • 2.10.2 Chembio Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
    • 2.10.3 Chembio Diagnostics SWOT Analysis
    • 2.10.4 Chembio Diagnostics Product and Services
    • 2.10.5 Chembio Diagnostics COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
  • 2.11 Guangdong Hecin-Scientific
    • 2.11.1 Guangdong Hecin-Scientific Details
    • 2.11.2 Guangdong Hecin-Scientific Major Business and Total Revenue (Financial Highlights) Analysis
    • 2.11.3 Guangdong Hecin-Scientific SWOT Analysis
    • 2.11.4 Guangdong Hecin-Scientific Product and Services
    • 2.11.5 Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
  • 2.12 Ortho Clinical Diagnostics
    • 2.12.1 Ortho Clinical Diagnostics Details
    • 2.12.2 Ortho Clinical Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
    • 2.12.3 Ortho Clinical Diagnostics SWOT Analysis
    • 2.12.4 Ortho Clinical Diagnostics Product and Services
    • 2.12.5 Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
  • 2.13 Dynamiker Biotechnology (Tianjin)
    • 2.13.1 Dynamiker Biotechnology (Tianjin) Details
    • 2.13.2 Dynamiker Biotechnology (Tianjin) Major Business and Total Revenue (Financial Highlights) Analysis
    • 2.13.3 Dynamiker Biotechnology (Tianjin) SWOT Analysis
    • 2.13.4 Dynamiker Biotechnology (Tianjin) Product and Services
    • 2.13.5 Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
  • 2.14 Guangzhou Wondfo Biotech
    • 2.14.1 Guangzhou Wondfo Biotech Details
    • 2.14.2 Guangzhou Wondfo Biotech Major Business and Total Revenue (Financial Highlights) Analysis
    • 2.14.3 Guangzhou Wondfo Biotech SWOT Analysis
    • 2.14.4 Guangzhou Wondfo Biotech Product and Services
    • 2.14.5 Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
  • 2.15 Zhejiang Orient Gene Biotech
    • 2.15.1 Zhejiang Orient Gene Biotech Details
    • 2.15.2 Zhejiang Orient Gene Biotech Major Business and Total Revenue (Financial Highlights) Analysis
    • 2.15.3 Zhejiang Orient Gene Biotech SWOT Analysis
    • 2.15.4 Zhejiang Orient Gene Biotech Product and Services
    • 2.15.5 Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
  • 2.16 ADVAITE
    • 2.16.1 ADVAITE Details
    • 2.16.2 ADVAITE Major Business and Total Revenue (Financial Highlights) Analysis
    • 2.16.3 ADVAITE SWOT Analysis
    • 2.16.4 ADVAITE Product and Services
    • 2.16.5 ADVAITE COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
  • 2.17 Innovita Biological Technology
    • 2.17.1 Innovita Biological Technology Details
    • 2.17.2 Innovita Biological Technology Major Business and Total Revenue (Financial Highlights) Analysis
    • 2.17.3 Innovita Biological Technology SWOT Analysis
    • 2.17.4 Innovita Biological Technology Product and Services
    • 2.17.5 Innovita Biological Technology COVID-19 In-Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

  • 3.1 Global COVID-19 In-Vitro Diagnostics Revenue and Share by Players (2015-2020)
  • 3.2 Market Concentration Rate
    • 3.2.1 Top 5 COVID-19 In-Vitro Diagnostics Players Market Share
    • 3.2.2 Top 10 COVID-19 In-Vitro Diagnostics Players Market Share
  • 3.3 Market Competition Trend

4 Market Size by Regions

  • 4.1 Global COVID-19 In-Vitro Diagnostics Revenue and Market Share by Regions
  • 4.2 North America COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)
  • 4.3 Europe COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)
  • 4.4 Asia-Pacific COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)
  • 4.5 South America COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)
  • 4.6 Middle East & Africa COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)

5 North America COVID-19 In-Vitro Diagnostics Revenue by Countries

  • 5.1 North America COVID-19 In-Vitro Diagnostics Revenue by Countries (2015-2020)
  • 5.2 USA COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)
  • 5.3 Canada COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)
  • 5.4 Mexico COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)

6 Europe COVID-19 In-Vitro Diagnostics Revenue by Countries

  • 6.1 Europe COVID-19 In-Vitro Diagnostics Revenue by Countries (2015-2020)
  • 6.2 Germany COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)
  • 6.3 UK COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)
  • 6.4 France COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)
  • 6.5 Russia COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)
  • 6.6 Italy COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)

7 Asia-Pacific COVID-19 In-Vitro Diagnostics Revenue by Countries

  • 7.1 Asia-Pacific COVID-19 In-Vitro Diagnostics Revenue by Countries (2015-2020)
  • 7.2 China COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)
  • 7.3 Japan COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)
  • 7.4 Korea COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)
  • 7.5 India COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)
  • 7.6 Southeast Asia COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)

8 South America COVID-19 In-Vitro Diagnostics Revenue by Countries

  • 8.1 South America COVID-19 In-Vitro Diagnostics Revenue by Countries (2015-2020)
  • 8.2 Brazil COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)
  • 8.3 Argentina COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue COVID-19 In-Vitro Diagnostics by Countries

  • 9.1 Middle East & Africa COVID-19 In-Vitro Diagnostics Revenue by Countries (2015-2020)
  • 9.2 Saudi Arabia COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)
  • 9.3 UAE COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)
  • 9.4 Egypt COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)
  • 9.5 South Africa COVID-19 In-Vitro Diagnostics Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

  • 10.1 Global COVID-19 In-Vitro Diagnostics Revenue and Market Share by Type (2015-2020)
  • 10.2 Global COVID-19 In-Vitro Diagnostics Market Forecast by Type (2019-2024)
  • 10.3 Rapid Diagnostic Test (RDT) Revenue Growth Rate (2015-2025)
  • 10.4 Enzyme Linked Immunosorbent Assay (ELISA) Revenue Growth Rate (2015-2025)
  • 10.5 Neutralization Assay Revenue Growth Rate (2015-2025)

11 Global COVID-19 In-Vitro Diagnostics Market Segment by Application

  • 11.1 Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Application (2015-2020)
  • 11.2 COVID-19 In-Vitro Diagnostics Market Forecast by Application (2019-2024)
  • 11.3 Home Revenue Growth (2015-2020)
  • 11.4 Hospital Revenue Growth (2015-2020)
  • 11.5 Clinical Revenue Growth (2015-2020)

12 Global COVID-19 In-Vitro Diagnostics Market Size Forecast (2021-2025)

  • 12.1 Global COVID-19 In-Vitro Diagnostics Market Size Forecast (2021-2025)
  • 12.2 Global COVID-19 In-Vitro Diagnostics Market Forecast by Regions (2021-2025)
  • 12.3 North America COVID-19 In-Vitro Diagnostics Revenue Market Forecast (2021-2025)
  • 12.4 Europe COVID-19 In-Vitro Diagnostics Revenue Market Forecast (2021-2025)
  • 12.5 Asia-Pacific COVID-19 In-Vitro Diagnostics Revenue Market Forecast (2021-2025)
  • 12.6 South America COVID-19 In-Vitro Diagnostics Revenue Market Forecast (2021-2025)
  • 12.7 Middle East & Africa COVID-19 In-Vitro Diagnostics Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Data Source
    • 14.3 Disclaimer

    Market Overview
    The COVID-19 In-Vitro Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

    The most likely (base case) scenario is that the global COVID-19 In-Vitro Diagnostics sales will be xx in 2020 from COVID-19 In-Vitro Diagnostics million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global COVID-19 In-Vitro Diagnostics market size is expected to grow at xx% or more annually for the next five years.

    This report also researches and evaluates the impact of Covid-19 outbreak on the COVID-19 In-Vitro Diagnostics industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on COVID-19 In-Vitro Diagnostics and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

    Market segmentation
    COVID-19 In-Vitro Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

    By Type, COVID-19 In-Vitro Diagnostics market has been segmented into:
    Rapid Diagnostic Test (RDT)
    Enzyme Linked Immunosorbent Assay (ELISA)
    Neutralization Assay

    By Application, COVID-19 In-Vitro Diagnostics has been segmented into:
    Home
    Hospital
    Clinical

    Regions and Countries Level Analysis
    Regional analysis is another highly comprehensive part of the research and analysis study of the global COVID-19 In-Vitro Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level COVID-19 In-Vitro Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global COVID-19 In-Vitro Diagnostics market.

    The report offers in-depth assessment of the growth and other aspects of the COVID-19 In-Vitro Diagnostics market in important countries (regions), including:
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia and Italy)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
    South America (Brazil, Argentina, Colombia)
    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

    Competitive Landscape and COVID-19 In-Vitro Diagnostics Market Share Analysis
    COVID-19 In-Vitro Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, COVID-19 In-Vitro Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the COVID-19 In-Vitro Diagnostics sales, revenue and market share for each player covered in this report.

    The major players covered in COVID-19 In-Vitro Diagnostics are:
    Cellex
    Mayo Clinic Laboratories
    BioMedomics
    Abbott
    Safecare Bio-Tech
    Roche
    Mount Sinai Laboratory
    Henry Schein
    BD
    Chembio Diagnostics
    Guangdong Hecin-Scientific
    Ortho Clinical Diagnostics
    Dynamiker Biotechnology (Tianjin)
    Guangzhou Wondfo Biotech
    Zhejiang Orient Gene Biotech
    ADVAITE
    Innovita Biological Technology
    Among other players domestic and global, COVID-19 In-Vitro Diagnostics market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
    Buy now